Navigation Links
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers
Date:4/17/2008

ects and widespread use can lead to development of bacterial resistance. Furthermore, diabetic ulcers are often associated with vascular disease and restricted peripheral blood flow (ischemia), which may render systemically acting antibiotics less effective. Infection can also spread to the bone (osteomyelitis), which is less well vascularized than soft tissue. Currently, there are no topically applied antibiotics marketed in the US that are specifically indicated for the treatment of infected diabetic foot ulcers and recent market research independently performed by L.E.K. Consulting forecast peak annual US sales revenues for CollaRx GENTAMICIN TOPICAL approaching US$270 million, when limiting the sales projections to diabetic foot indications only.

CollaRx GENTAMICIN TOPICAL is currently under investigation for the treatment and prevention of diabetic foot infections of varying severity in a series of multi-centred phase 2 clinical trials. The first of these trials, which commenced in late 2007, is investigating the product as a mono-antibiotic therapy for the treatment of mildly infected diabetic ulcers where the safety and efficacy of CollaRx GENTAMICIN TOPICAL will be compared to an orally administered antibiotic (the current standard of care). This second phase 2 trial will investigate the product as an adjunct to systemic antibiotic therapy for treating moderately infected ulcers, as defined according to Infectious Disease Society of America (IDSA) guidelines. The third phase 2 trial, planned to commence later this month, will investigate the product for the prevention of infection in diabetic foot ulcers.

Dr. Michael Myers, Innocoll's President and CEO commented, "Our Gentamicin-Collagen sponge is already used successfully in Europe and elsewhere as an adjunct for the treatment diabetic foot infections, where physicians have reported it can help to salvage limbs that may otherwise be amputated. Since there are currently no topical antibiotics o
'/>"/>

SOURCE Innocoll Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
2. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
3. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
4. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
5. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
6. ViroPharma Announces Discontinuation of HCV-796 Development
7. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
8. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
9. Phreesia Announces Clinical Initiative to Better Manage Symptoms of Parkinsons Disease
10. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
11. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... --  Mallinckrodt plc (NYSE: MNK ), a leading ... at the Bank of America Merrill Lynch 2015 Health Care ... Las Vegas, Nev. Matthew ... Cole Lannum , Senior Vice President of Investor Strategy ... session scheduled to begin at 3 p.m. Eastern / noon ...
(Date:5/4/2015)... 2015  Array BioPharma Inc. (NASDAQ: ARRY ... of its fiscal year ending June 30, 2015. ... noted, "With the close of the Novartis-GSK transaction, ... innovative oncology products in Phase 3, with plans ... These transformative transactions have accelerated our path to ...
(Date:5/4/2015)... , May 4, 2015  Prometheus Research ... the American Optometric Association (AOA) to build a ... outcomes for the millions of patients treated by ... Outcomes Registry for Eyecare (MORE) will leverage ... facilitate efficient secondary uses of essential health and ...
Breaking Medicine Technology:Mallinckrodt To Present At Bank Of America Merrill Lynch 2015 Health Care Conference 2Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 10American Optometric Association, Prometheus Research to Create Transformative Health Outcomes Registry 2
... Sept. 14 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Business Development of BioMarin, will present a company update at ... on Tuesday, September 21, 2010 at 3:30 p.m. ET.   ... of the conference call via the investor section of the ...
... WORCESTER, Mass., Sept. 14 Generex Biotechnology Corporation (Nasdaq: ... in drug delivery for metabolic diseases through the inner ... entered into an exclusive Product Licensing & Distribution Agreement ... marketing, distribution and sale of Generex Oral-lyn™, the Company,s ...
Cached Medicine Technology:BioMarin to Present at the UBS Global Life Sciences Conference 2Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile 2Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile 3
(Date:5/4/2015)... Elisabeth Rosenthal’s article* on “balance billing” ... the healthcare fraternity as well as patients about ... of balance billing. In definition, balance billing is ... patient for the difference between what the patient's ... provider chooses to charge. Rosenthal’s article talks about ...
(Date:5/4/2015)... May 04, 2015 For partners who’d ... new lubricant -- Astroglide TTC™ (Trying to Conceive) ... and alter pH levels, Astroglide TTC™ is specially formulated ... According to the Centers for Disease Control, an average ... getting pregnant or sustaining a pregnancy, and over ...
(Date:5/4/2015)... Peacock Alley knows we all ... “My mother was the most beautiful woman I ever saw.” ... feminine prints and textures to remind her just ... the Eloise Robe to get you there. The beautiful Monet-inspired ... and tapered waist. It is available in small/medium or large/extra ...
(Date:5/3/2015)... (PRWEB) May 03, 2015 Barbara Crone has joined ... enhance the well being of the men, women and families who ... followed by providing care for families in the home. ... Nurse Practitioner began wondering if I could complete their care with ... own children with my mentor Nurse Midwife, I knew it was ...
(Date:5/3/2015)... Indiana (PRWEB) May 03, 2015 Indiana ... Service Provider announces Bank Computer Services, Inc (BCS) has ... Prout, BCS’ President states, “The technology, service, and working ... really like is the local feel you get with ... and managed company; IFN makes local decisions and operates ...
Breaking Medicine News(10 mins):Health News:Out of Network Balance Billing Without Being Viewed as Fraud 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 3Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 2Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 3Health News:Feminine Classics for Mother's Day Gifts from Peacock Alley 2Health News:Women's Excellence In Midwifery Welcomes Barbara Crone 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 3
... women should consider the real cost of the procedure beyond the ... surgeon, advises of the importance of choosing a cosmetic surgeon wisely based ... ... Paramus, NJ (PRWeb) January 27, 2009 - You may be under the ...
... Solutions ( http://www.ahsrcm.com ), a leading provider of ... it has entered into an agreement with Staten ... of physician billing and A/R management services for ... the agreement, AHS will acquire the existing SIUH ...
... Attorneys representing individual physicians and the physician partnership ... praised today,s announcement that Texas Attorney General Greg ... similar violations of the state antitrust laws.The Attorney ... an agreed injunction prohibiting Memorial Hermann from engaging ...
... Withholding Eucharist From Pro-Abortion Catholic PelosiWASHINGTON, Jan. 26 ... Kenney issued the following statement today regarding Speaker of ... Sunday. Rep. Pelosi stated that the millions of dollars ... "reduce costs to the states and to the federal ...
... American Heart Association science advisory concludes that omega-6 fatty acids ... are a beneficial part of a heart-healthy eating plan. ... issue of Circulation: Journal of the American Heart Association. ... Fatty Acids Click here for the full ...
... be hidden in DNA , , MONDAY, Jan. 26 (HealthDay News) ... make you human are genes that may determine whether you ... two types of twins shows that genetics might affect social ... are closing in on some of those "personality" genes. , ...
Cached Medicine News:Health News:Interested in Breast Augmentation, New Jersey? Be Sure You Know the “Real Cost” 2Health News:Interested in Breast Augmentation, New Jersey? Be Sure You Know the “Real Cost” 3Health News:Interested in Breast Augmentation, New Jersey? Be Sure You Know the “Real Cost” 4Health News:Staten Island University Hospital Chooses Advantedge Healthcare Solutions for Employed Physician Billing 2Health News:Staten Island University Hospital Chooses Advantedge Healthcare Solutions for Employed Physician Billing 3Health News:Staten Island University Hospital Chooses Advantedge Healthcare Solutions for Employed Physician Billing 4Health News:Lawyers React to Texas Attorney General's Lawsuit, Settlement Against Houston's Memorial Hermann 2Health News:American Life League Statement on Pelosi's State-Enforced War on Preborn Babies 2Health News:Popular or Not? Your Genes May Help Decide 2Health News:Popular or Not? Your Genes May Help Decide 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: